or Try an Advanced Search...

    Diabetic Nephropathy Stocks List

    Symbol Grade Name % Change
    MESO B Mesoblast Limited -11.31
    BMY B Bristol-Myers Squibb Company -3.90
    INCY B Incyte Corporation -2.39
    CYCN D Cyclerion Therapeutics, Inc. 45.76
    XRTX F XORTX Therapeutics Inc. -8.02
    AMPE F Ampio Pharmaceuticals, Inc. 0.00
    ZVSA F ZyVersa Therapeutics, Inc. -4.42
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Kidney Disease Organ Systems Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences Medicine Rheumatoid Arthritis S&P 500 Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autoimmune Disease Autosomal Dominant Polycystic Kidney Disease Back Pain Biopharmaceutical Products

    Related ETFs - A few ETFs which own one or more of the above listed Diabetic Nephropathy stocks.

    Symbol Grade Name Weight
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 8.67
    MEDX F Horizon Kinetics Medical ETF 5.67
    PPH D Market Vectors Pharmaceutical ETF 5.41
    MVAL C SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF 5.37
    IDNA D iShares Genomics Immunology and Healthcare ETF 5.36
    View all Diabetic Nephropathy ETFs...
    Compare ETFs
    Compare FTXH to MVAL Compare MEDX to IDNA Compare MVAL to IDNA

        Diabetic Nephropathy Stocks Recent News

        Date Stock Title
        Nov 15 XRTX XORTX Therapeutics files to sell 810,810 common shares for holders
        Nov 15 BMY Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
        Nov 15 BMY Bristol Myers gets positive EMA opinion for repotrectinib
        Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer
        Nov 15 BMY Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors
        Nov 14 BMY Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
        Nov 14 BMY Tudor Investment adds Infinera, Trane, exits Disney, UnitedHealth, among top Q3 trades
        Nov 14 ZVSA ZyVersa Therapeutics GAAP EPS of -$2.43 misses by $0.83
        Nov 14 BMY Bristol-Myers Squibb Company's (NYSE:BMY) high institutional ownership speaks for itself as stock continues to impress, up 5.7% over last week
        Nov 14 ZVSA ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
        Nov 14 BMY 2 Beaten-Down Dividend Stocks to Buy and Hold
        Nov 14 INCY Incyte to Present at Upcoming Investor Conference
        Nov 13 BMY Avidity Bio Has Surged 416% This Year — And That's Before Today's 'Game-Changing' News
        Nov 13 BMY Is Bristol-Myers Squibb Company (BMY) Among The Top Dividend Contenders Right Now?
        Nov 12 BMY 3 Stocks Seeing Insider Buys: CNC, PFE, BMY
        Nov 12 BMY Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
        Nov 12 BMY AbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains
        Nov 12 ZVSA Life Sciences Investor Forum Agenda Announced for November 14th
        Nov 12 BMY Bristol-Myers upgraded at Leerink after AbbVie setback
        Nov 12 BMY What the NFL Draft Can Teach Investors About Big Pharma
        Related Industries: Biotechnology Data Storage Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Kidney Disease Organ Systems Diabetes Heart Failure Inflammation Inflammatory Conditions Kidney Life Sciences Medicine Rheumatoid Arthritis S&P 500 Adult Stem Cell Alport Syndrome Antioxidant Atrial Fibrillation Autoimmune Disease Autosomal Dominant Polycystic Kidney Disease Back Pain Biopharmaceutical Products
        Diabetic Nephropathy

        Diabetic nephropathy is a type of kidney disease that is caused by damage to the blood vessels in the kidneys due to diabetes. It is a serious complication of diabetes and can lead to kidney failure. Symptoms of diabetic nephropathy include high blood pressure, swelling in the legs and feet, and protein in the urine. Treatment for diabetic nephropathy includes controlling blood sugar levels, taking medications to reduce blood pressure, and following a healthy diet.

        Browse All Tags